Altered behavior, brain structure, and neurometabolites in a rat model of autism-specific maternal autoantibody exposure.
Saved in:
| Title: | Altered behavior, brain structure, and neurometabolites in a rat model of autism-specific maternal autoantibody exposure. |
|---|---|
| Authors: | Bruce MR; Department of Internal Medicine, Division of Rheumatology, Allergy, and Clinical Immunology, University of California, Davis, CA, USA., Couch ACM; Department of Basic and Clinical Neuroscience, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK., Grant S; Department of Psychiatry and Behavioral Sciences, University of California, Davis, CA, USA., McLellan J; Department of Internal Medicine, Division of Rheumatology, Allergy, and Clinical Immunology, University of California, Davis, CA, USA., Ku K; Department of Psychiatry and Behavioral Sciences, University of California, Davis, CA, USA., Chang C; Department of Psychiatry and Behavioral Sciences, University of California, Davis, CA, USA., Bachman A; Department of Psychiatry and Behavioral Sciences, University of California, Davis, CA, USA., Matson M; Department of Psychiatry and Behavioral Sciences, University of California, Davis, CA, USA., Berman RF; Department of Neurological Surgery, University of California, Davis, CA, USA.; MIND Institute, University of California, Davis, CA, USA., Maddock RJ; Department of Psychiatry and Behavioral Sciences, University of California, Davis, CA, USA., Rowland D; Center for Molecular and Genomic Imaging, University of California, Davis, CA, USA., Kim E; Department of Neuroimaging, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK., Ponzini MD; Department of Neuroimaging, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK., Harvey D; Department of Public Health Sciences, University of California, Davis, CA, USA., Taylor SL; Department of Public Health Sciences, University of California, Davis, CA, USA., Vernon AC; Department of Basic and Clinical Neuroscience, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.; MRC Centre for Neurodevelopmental Disorders, King's College London, London, UK., Bauman MD; Department of Psychiatry and Behavioral Sciences, University of California, Davis, CA, USA.; MIND Institute, University of California, Davis, CA, USA., Van de Water J; Department of Internal Medicine, Division of Rheumatology, Allergy, and Clinical Immunology, University of California, Davis, CA, USA. javandewater@ucdavis.edu.; MIND Institute, University of California, Davis, CA, USA. javandewater@ucdavis.edu. |
| Source: | Molecular psychiatry [Mol Psychiatry] 2023 May; Vol. 28 (5), pp. 2136-2147. Date of Electronic Publication: 2023 Mar 27. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Nature Publishing Group Specialist Journals Country of Publication: England NLM ID: 9607835 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5578 (Electronic) Linking ISSN: 13594184 NLM ISO Abbreviation: Mol Psychiatry Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
